Mycophenolate Mofetil for Oral Suspension, USP

REMS Prescribing Information/Medication Guide Safety Sheet NDC:  Unit Size/Quantity:  Indication: For the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. Please see full Prescribing Information for more information. Storage and Handling: Store dry powder at 20°C […]

Tuberculin, Purified Protein Derivative, Diluted Injection 5TU/0.1mL

Prescribing Information Safety Sheet Product Overview NDC:  Unit Size/Quantity:  Indication: Tuberculin PPD is indicated as an aid in the detection of infection with Mycobacterium tuberculosis. Please see full Prescribing Information for more information. Markings: N/A Storage and Handling: DO NOT FREEZE This product should be stored between 2° and 8°C (36° and 46°F) and protected […]

Tuberculin, Purified Protein Derivative, Diluted Injection 5TU/0.1mL

Prescribing Information Safety Sheet Product Overview NDC:  Unit Size/Quantity:  Indication: Tuberculin PPD is indicated as an aid in the detection of infection with Mycobacterium tuberculosis. Please see full Prescribing Information for more information. Markings: N/A Storage and Handling: DO NOT FREEZE This product should be stored between 2° and 8°C (36° and 46°F) and protected […]

Naloxone HCl Injection, USP

Prescribing Information Safety Sheet Product Overview NDC:  Unit Size/Quantity:  Indication: ZIMHI™ is an opioid antagonist indicated in adult and pediatric patients for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.  ZIMHI is intended for immediate administration as emergency therapy in settings where opioids may be present. […]

Naltrexone HCl 50 mg Tablet

Prescribing Information Safety Sheet Product Overview NDC:  Unit Size/Quantity:  Indication: Naltrexone hydrochloride tablets are indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. Naltrexone hydrochloride has not been shown to provide any therapeutic benefit except as part of an appropriate plan of management for the addictions. […]

You are now leaving vistapharm.com.

Click ‘OK’ to proceed or ‘CANCEL’ to return to the current page.
This website uses cookies

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand where our visitors are coming from.

You are now leaving vistapharm.com.

Click ‘OK’ to proceed or ‘CANCEL’ to return to the current page.

You are now leaving vistapharm.com.

Click ‘OK’ to proceed or ‘CANCEL’ to return to the current page.

You are now leaving vistapharm.com.

Click ‘OK’ to proceed or ‘CANCEL’ to return to the current page.

You are now leaving vistapharm.com.

Click ‘OK’ to proceed or ‘CANCEL’ to return to the current page.